Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05565079 · ClinicalTrials.gov registry record · Phase 4
Root Coverage Using ADM and Coronally Positioned Tunnel With or Without Enamel Matrix Derivative
A Phase 4 study, sponsored by University of Louisville.
- Completed
- Registry status
- Phase 4
- Development phase
- 24
- Enrollment target
NCT05565079: Completed Phase 4 study, sponsored by University of Louisville.
NCT05565079 is a Phase 4 study that has completed, run by University of Louisville. The registered enrollment target is 24 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (95% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05565079, a Phase 4 study, has completed, sponsored by University of Louisville.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 24 participants
- Enrollment target
Study Summary
24 patients will be treated with a coronally positioned tunnel with AlloDerm RTM with or without the addition of Enamel Matrix Derivative to compare the baseline and 6-month changes in recession defect coverage, clinical attachment levels, amount of keratinized tissue width, and soft tissue thickness.
Primary Outcome
To compare baseline and 6-month changes in recession defect coverage
Interventions
- BIOLOGICAL Regenerative tissue matrix and enamel matrix derivative
- BIOLOGICAL Regenerative tissue matrix
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
| Start Date | 2022-10-06 |
| Est. Completion | 2024-10-30 |
| Phase | Phase 4 |
What the finished NCT05565079 record still lists
NCT05565079 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 24 participants, a relatively small participant target, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (95% lower).
The record links to 0 conditions, and to 2 interventions - of which Regenerative tissue matrix and enamel matrix derivative is the first listed.
NCT05565079 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05565079 about?
NCT05565079 is a clinical study titled "Root Coverage Using ADM and Coronally Positioned Tunnel With or Without Enamel Matrix Derivative". 24 patients will be treated with a coronally positioned tunnel with AlloDerm RTM with or without the addition of Enamel Matrix Derivative to compare the baseline and 6-month changes in recession defect coverage, clinical attachment levels, amount of keratinized tissue width, and soft tissue thicknes...
What is the current status of trial NCT05565079?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 24 participants. The study started on 2022-10-06. Estimated completion is 2024-10-30.
What interventions are being tested in trial NCT05565079?
The interventions under investigation include: Regenerative tissue matrix and enamel matrix derivative (BIOLOGICAL), Regenerative tissue matrix (BIOLOGICAL).
Who is sponsoring clinical trial NCT05565079?
This trial is sponsored by University of Louisville, which has 217 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05565079's enrollment target sits among peer trials
24 1699th of 2000 higher than 276 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02331979 · 24 participants · NA
Improving Bladder Function in SCI by Neuromodulation
- NCT03096197 · 24 participants · NA
Exoskeleton and Spinal Cord Stimulation for SCI
- NCT03223922 · 24 participants · NA
Neurocognitive Functioning With Genu-Sparing Whole Brain Radiation Therapy for Brain Metastases
- NCT03326921 · 24 participants · Phase 1
HA-1 T TCR T Cell Immunotherapy for the Treatment of Patients With Relapsed or Refractory Acute Leukemia After Donor Stem Cell Transplant
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI